SHAREHOLDER ALERT: Investigation of iRhythm Announced by Holzer & Holzer, LLC

Atlanta, Georgia--(Newsfile Corp. - January 29, 2021) - Holzer & Holzer, LLC is investigating whether iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) complied with federal securities laws. On January 29, 2021, a Baird research analyst indicated that Novartis, a Medicare Administrative Contractor, reimbursement rates concerning heart monitors are "way lower than" those published in the Medicare Physician Fee Schedule. The price of iRhythm's stock fell following the announcement.

If you purchased shares of iRhythm and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at or Luke R. Kennedy, Esq. at, or by toll-free telephone at (888) 508-6832 to discuss your legal rights or at

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.


Corey D. Holzer, Esq.
(888) 508-6832 (toll-free)

To view the source version of this press release, please visit